Toripalimab Plus Definitive Chemoradiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial
Lancet Oncol 2023 Apr 01;24(4)371-382, Y Zhu, J Wen, Q Li, B Chen, L Zhao, S Liu, Y Yang, S Wang, Y Lv, J Li, L Zhang, Y Hu, M Liu, M XiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.